140 related articles for article (PubMed ID: 37216165)
21. Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population.
Wang J; Sang D; Xu B; Yuan P; Ma F; Luo Y; Li Q; Zhang P; Cai R; Fan Y; Chen S; Li Q
Medicine (Baltimore); 2016 May; 95(18):e3518. PubMed ID: 27149453
[TBL] [Abstract][Full Text] [Related]
22. Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy.
Cabrera-Galeana P; Muñoz-Montaño W; Lara-Medina F; Alvarado-Miranda A; Pérez-Sánchez V; Villarreal-Garza C; Quintero RM; Porras-Reyes F; Bargallo-Rocha E; Del Carmen I; Mohar A; Arrieta O
Oncologist; 2018 Jun; 23(6):670-678. PubMed ID: 29490940
[TBL] [Abstract][Full Text] [Related]
23. Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.
Kashiwagi S; Yashiro M; Takashima T; Aomatsu N; Ikeda K; Ogawa Y; Ishikawa T; Hirakawa K
Breast Cancer Res; 2011; 13(6):R122. PubMed ID: 22126395
[TBL] [Abstract][Full Text] [Related]
24. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
25. Optimal adjuvant chemotherapy completion time for stage III colon cancer: a cohort study.
Ren JQ; Zhang HS; Zhang LH; Zhong QG; Wu F; Wang BL; Liu SJ
J Gastrointest Oncol; 2021 Aug; 12(4):1558-1567. PubMed ID: 34532110
[TBL] [Abstract][Full Text] [Related]
26. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
27. Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.
Fasching PA; Heusinger K; Haeberle L; Niklos M; Hein A; Bayer CM; Rauh C; Schulz-Wendtland R; Bani MR; Schrauder M; Kahmann L; Lux MP; Strehl JD; Hartmann A; Dimmler A; Beckmann MW; Wachter DL
BMC Cancer; 2011 Nov; 11():486. PubMed ID: 22081974
[TBL] [Abstract][Full Text] [Related]
28. Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients.
Zhang L; Deng Y; Liu S; Zhang W; Hong Z; Lu Z; Pan Z; Wu X; Peng J
BMC Cancer; 2023 Jan; 23(1):3. PubMed ID: 36593480
[TBL] [Abstract][Full Text] [Related]
29. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
[TBL] [Abstract][Full Text] [Related]
31. A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
Öhrling K; Karlberg M; Edler D; Hallström M; Ragnhammar P
Clin Colorectal Cancer; 2013 Jun; 12(2):128-35. PubMed ID: 23276521
[TBL] [Abstract][Full Text] [Related]
32. KI67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival.
Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
Arch Esp Urol; 1998 Mar; 51(2):204-10. PubMed ID: 9586325
[TBL] [Abstract][Full Text] [Related]
33. Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.
Jing Y; Yang Y; Hao F; Song Y; Zhang X; Zhang Y; Huang X; Hu Q; Ni Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341240
[No Abstract] [Full Text] [Related]
34. Role of Ki67 in predicting resistance to adjuvant tamoxifen in postmenopausal breast cancer patients.
Elzawahry HM; Saber MM; Mokhtar NM; Zeeneldin AA; Ismail YM; Alieldin NH
J Egypt Natl Canc Inst; 2013 Dec; 25(4):181-91. PubMed ID: 24207090
[TBL] [Abstract][Full Text] [Related]
35. ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.
Kim CY; Seo SH; An MS; Kim KH; Bae KB; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
Ann Coloproctol; 2015 Jun; 31(3):92-7. PubMed ID: 26161376
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in sporadic colon cancer with high-level microsatellite instability.
Oh BY; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
Surgery; 2016 May; 159(5):1372-81. PubMed ID: 26775578
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial.
Taieb J; Zaanan A; Le Malicot K; Julié C; Blons H; Mineur L; Bennouna J; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Lepage C; Emile JF; Laurent-Puig P
JAMA Oncol; 2016 May; 2(5):643-653. PubMed ID: 26768652
[TBL] [Abstract][Full Text] [Related]
38. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
Stavridi F; Kalogeras KT; Pliarchopoulou K; Wirtz RM; Alexopoulou Z; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
PLoS One; 2016; 11(10):e0164013. PubMed ID: 27695115
[TBL] [Abstract][Full Text] [Related]
40. The effect of smoking, obesity and diabetes on recurrence-free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy.
Croese A; Gartrell R; Hiscock R; Lee M; Gibbs P; Faragher I; Yeung J
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1346. PubMed ID: 33554476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
